HCA Holdings (NYSE: HCA) was upgraded by investment analysts at Citigroup from a “neutral” rating to a “buy” rating in a note issued to investors on Monday.
The analysts wrote, “[W]e are upgrading HCA from Neutral to Buy as we assume a more positive view of the near-term (30day) risk/reward around the Supreme Court’s healthcare reform ruling. We are reducing the regulatory risk adjustment in our current target price methodology. Our new target price of $33 represents ~10x ’13 P/E (excluding HCIT) and 7.3x EV/EBITDA without any effect of the healthcare reform law.”
Shares of HCA Holdings opened at 25.75 on Monday. HCA Holdings has a one year low of $17.03 and a one year high of $34.99. The company has a market cap of $11.299 billion and a P/E ratio of 4.61.
HCA Holdings last issued its quarterly earnings data on Thursday, May 3rd. The company reported $1.18 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.99 by $0.19. HCA Holdings’s revenue was up 4.3% compared to the same quarter last year. On average, analysts predict that HCA Holdings will post $0.79 earnings per share next quarter.
Separately, analysts at Cantor Fitzgerald initiated coverage on shares of HCA Holdings in a research note to investors on Thursday, March 22nd. They set a “buy” rating and a $30.00 price target on the stock.
HCA Holdings, Inc (HCA) is a non-governmental hospital operator in the United States and an integrated provider of health care and related services.
Stay on top of analysts' coverage with our daily email newsletter that provides a concise list of analysts' upgrades, analysts' downgrades and analysts' price target changes for each day. Click here to register.